• Target：
• SMYD2

• Fields：
• >>Lysine degradation;>>Metabolic pathways

• Gene Name：
• smyd2

• Human Gene Id：
• 56950

• Human Swiss Prot No：
• Q9NRG4

• Mouse Swiss Prot No：
• Q8R5A0

• Immunogen：
• Purified recombinant human KMT3C / SMYD2 protein fragments expressed in E.coli.

• Specificity：
• This antibody detects endogenous levels of KMT3C / SMYD2 and does not cross-react with related proteins.

• Formulation：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• Source：
• Monoclonal, Mouse

• Dilution：
• wb 1:1000

• Purification：
• The antibody was affinity-purified from mouse ascites by affinity-chromatography using epitope-specific immunogen.

• Concentration：
• 1 mg/ml

• Storage Stability：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• Other Name：
• Histone methyltransferase SMYD2;HSKM B;HSKM-B;HSKMB;KMT3C;Lysine N-methyltransferase 3C;MGC119305;N lysine methyltransferase SMYD2;N-lysine methyltransferase SMYD2;SET and MYND domain containing 2;SET and MYND domain containing protein 2;SET and MYND domain-containing protein 2;Smyd2;SMYD2_HUMAN;Zinc finger MYND domain containing 14;ZMYND14.

• Observed Band(KD)：
• 50kD

• Background：
• SET and MYND domain containing 2(SMYD2) Homo sapiens SET domain-containing proteins, such as SMYD2, catalyze lysine methylation (Brown et al., 2006 [PubMed 16805913]).[supplied by OMIM, Nov 2008],

• Function：
• similarity:Contains 1 MYND-type zinc finger.,similarity:Contains 1 SET domain.,

• Subcellular Location：
• Cytoplasm, cytosol . Nucleus .

• Expression：
• Brain,Colon,Liver cancer,Testis,

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs